Alpha-helical cationic antimicrobial peptides: relationships of structure and function
- PMID: 21203984
- PMCID: PMC4875170
- DOI: 10.1007/s13238-010-0004-3
Alpha-helical cationic antimicrobial peptides: relationships of structure and function
Abstract
Antimicrobial peptides (AMPs), with their extraordinary properties, such as broad-spectrum activity, rapid action and difficult development of resistance, have become promising molecules as new antibiotics. Despite their various mechanisms of action, the interaction of AMPs with the bacterial cell membrane is the key step for their mode of action. Moreover, it is generally accepted that the membrane is the primary target of most AMPs, and the interaction between AMPs and eukaryotic cell membranes (causing toxicity to host cells) limits their clinical application. Therefore, researchers are engaged in reforming or de novo designing AMPs as a 'single-edged sword' that contains high antimicrobial activity yet low cytotoxicity against eukaryotic cells. To improve the antimicrobial activity of AMPs, the relationship between the structure and function of AMPs has been rigorously pursued. In this review, we focus on the current knowledge of α-helical cationic antimicrobial peptides, one of the most common types of AMPs in nature.
Similar articles
-
Intracellular biomass flocculation as a key mechanism of rapid bacterial killing by cationic, amphipathic antimicrobial peptides and peptoids.Sci Rep. 2017 Dec 1;7(1):16718. doi: 10.1038/s41598-017-16180-0. Sci Rep. 2017. PMID: 29196622 Free PMC article.
-
Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties.Amino Acids. 2016 Feb;48(2):505-22. doi: 10.1007/s00726-015-2104-0. Epub 2015 Oct 8. Amino Acids. 2016. PMID: 26450121
-
Synthetic cationic amphiphilic α-helical peptides as antimicrobial agents.Biomaterials. 2011 Mar;32(8):2204-12. doi: 10.1016/j.biomaterials.2010.11.054. Epub 2010 Dec 18. Biomaterials. 2011. PMID: 21168911
-
The expanding scope of antimicrobial peptide structures and their modes of action.Trends Biotechnol. 2011 Sep;29(9):464-72. doi: 10.1016/j.tibtech.2011.05.001. Epub 2011 Jun 15. Trends Biotechnol. 2011. PMID: 21680034 Review.
-
Antimicrobial peptides (AMPs): A promising class of antimicrobial compounds.J Appl Microbiol. 2022 Mar;132(3):1573-1596. doi: 10.1111/jam.15314. Epub 2021 Oct 13. J Appl Microbiol. 2022. PMID: 34606679 Review.
Cited by
-
Exploring the pharmacological potential of promiscuous host-defense peptides: from natural screenings to biotechnological applications.Front Microbiol. 2011 Nov 22;2:232. doi: 10.3389/fmicb.2011.00232. eCollection 2011. Front Microbiol. 2011. PMID: 22125552 Free PMC article.
-
Design and Pharmacodynamics of Recombinant Fungus Defensin NZL with Improved Activity against Staphylococcus hyicus In Vitro and In Vivo.Int J Mol Sci. 2021 May 21;22(11):5435. doi: 10.3390/ijms22115435. Int J Mol Sci. 2021. PMID: 34063982 Free PMC article.
-
A Novel Bacitracin-like Peptide from Mangrove-Isolated Bacillus paralicheniformis NNS4-3 against MRSA and Its Genomic Insights.Antibiotics (Basel). 2024 Jul 30;13(8):716. doi: 10.3390/antibiotics13080716. Antibiotics (Basel). 2024. PMID: 39200016 Free PMC article.
-
Effect of Non-natural Hydrophobic Amino Acids on the Efficacy and Properties of the Antimicrobial Peptide C18G.Probiotics Antimicrob Proteins. 2021 Apr;13(2):527-541. doi: 10.1007/s12602-020-09701-3. Probiotics Antimicrob Proteins. 2021. PMID: 32889698 Free PMC article.
-
Optimized Antimicrobial Peptide Jelleine-I Derivative Br-J-I Inhibits Fusobacterium Nucleatum to Suppress Colorectal Cancer Progression.Int J Mol Sci. 2023 Jan 11;24(2):1469. doi: 10.3390/ijms24021469. Int J Mol Sci. 2023. PMID: 36674985 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources